An Experimental Treatment for Pulmonary Arterial Hypertension Just Earned Orphan Drug Designation
<a href="https://pixabay.com/users/Versatilevick_media/">Versatilevick_media</a> / Pixabay

An Experimental Treatment for Pulmonary Arterial Hypertension Just Earned Orphan Drug Designation

According to a story from firstworldpharma.com, the biopharmaceutical company Acceleron Pharma, Inc., recently announced that the company's experimental product candidate sotatercept has earned Orphan Drug designation from the US Food…

Continue Reading
New Rare Diseases Have Been Added to the Patient Advocate Foundation’s Co-Pay Relief Program
<a href="https://pixabay.com/users/QuinceMedia/">QuinceMedia</a> / Pixabay

New Rare Diseases Have Been Added to the Patient Advocate Foundation’s Co-Pay Relief Program

The Patient Advocate Foundation has recently begun to expand the reach of its popular Co-Pay Relief program. The Co-Pay Relief program is designed to provide financial assistance to qualifying patients.…

Continue Reading
  • 1
  • 2
Close Menu